FIGO regularly issues statements and joint statements. Filter Adolescence and Youth Health Adolescent Health Breast Health FIGO World Congress FIGO Regional Congress Events FIGO CPD FIGO Global Webinar Health Systems Strengthening Infections During Pregnancy Menopausal Age Reproductive Age Well Woman Health Technology Newborn Health Surgery STIs Safe Abortion Refugees Postpartum Hemorrhage Oncology Obstetric Fistula NCDS Environmental Health Medical Ethics Maternal Health Healthy Ageing Health for All Gynaecology and Technology FGM Fertility Family Planning Women's Health Rights Reset 01/03/2023 Guidance on the use of heat-stable carbetocin as an alternative to oxytocin in the prevention of postpartum haemorrhage Read More 18/10/2021 Uterine balloon tamponade for the management of postpartum haemorrhage within health systems Read More 30/06/2021 Joint statement of recommendation for the use of uterotonics for the prevention of postpartum haemorrhage Read More 30/06/2021 Joint statement of recommendation for the use of tranexamic acid for the treatment of postpartum haemorrhage Read More 30/03/2020 Fertility Treatment and COVID-19 – April 2020 guidance Read More 30/03/2020 COVID-19 & Management of Gynecological Cancers – March 2020 guidance Read More 30/03/2020 Non-Communicable Diseases and COVID-19 – March 2020 guidance Read More 03/01/2020 Statement on Third High Level Meeting on NCDs Read More Pagination Current page 1 Page 2 Page 3 Next page >
